Breakeven fiscal third quarter for Coty

By: Miguel A. Rodriguez

17:07, 10 May 2021

One of the most prominent beauty companies in the world posted fiscal third-quarter figures that came in line with expectations

Coty revealed that its revenues came in 3.3% lower as the COVID-19 lockdowns impacted sales. Its revenue from continuing operations fell to $1.03 billion in Q3 from $1.06 billion previously reported. In its report, Coty included an operating loss of $1.4 million, which was significantly lower compared to last year’s figures of $299.5 million.

For the future, Coty expects to end the year with its net revenue to reach a high of $4.6 billion and increase commercial investments to support its strategic priorities and improve sell-out trends as the beauty market begins to recover.

After the news hit the wires, Coty stock price fell 4.1%.


Share this article

This information prepared by is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.